Internal Medicine, Gastroenterology · Ogden, UT
NPI
1285959114
Since 2010
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
5740 Crestwood Dr
Ogden, UT, 84405
Phone (801) 475-3380
Groups this clinician bills Medicare through
Medicare paid, 2024
$64K
595 services
Medicare patients, 2024
341
Average age 72
Drug cost, 2024
$66K
685 prescriptions
Company payments, 2025
$466
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joshua G Vandersteen was code 43239 (upper gi endoscopy), 144 times for 132 patients. In total Joshua G Vandersteen billed 595 services in 57 codes, and Medicare paid $64K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 43239 Upper GI Endoscopy | Facility | 144 | 132 | $67.93 | $9,782 |
| 45385 Colonoscopy - Lesion Removal | Facility | 118 | 118 | $197.05 | $23K |
| 45380 Lower GI Endoscopy - Other | Facility | 36 | 35 | $106.75 | $3,843 |
| 43450 Digestive/Gastrointestinal | Facility | 33 | 33 | $27.88 | $920 |
| 43249 Upper GI Endoscopy | Facility | 25 | 20 | $88.10 | $2,202 |
| 45378 Lower GI Endoscopy - Other | Facility | 21 | 21 | $128.27 | $2,694 |
| 99213 Office E&M - Established | Office | 19 | 17 | $58.04 | $1,103 |
| 43235 Upper GI Endoscopy | Facility | 17 | 17 | $80.83 | $1,374 |
| 74328 Digestive/Gastrointestinal | Facility | 16 | 13 | $17.35 | $278 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 14 | 14 | $172.15 | $2,410 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 12 | 12 | $165.12 | $1,981 |
| 43453 Digestive/Gastrointestinal | Facility | 11 | 11 | $26.84 | $295 |
By year: 2022 $68K for 780 services; 2023 $79K for 713 services; 2024 $64K for 595 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 18 | 15 | $2.69 | $48.4 |
Medicare prescription drug claims, 2024
In 2024, the drug Joshua G Vandersteen prescribed most often to Medicare patients was Omeprazole, with 188 prescriptions and refills. In total Joshua G Vandersteen wrote 685 Medicare prescriptions that cost $66K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 188 | 440 | 108 | $4,577 |
| Suflave Peg 3350/Sod Sulf,chlr/Pot/Mag | 119 | 119 | 116 | $15K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 82 | 92 | 82 | $5,476 |
| Pantoprazole Sodium Generic | 40 | 116 | 21 | $656 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 30 | 30 | 28 | $464 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 27 | 27 | 27 | $4,659 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 24 | 24 | 24 | $3,931 |
| Rabeprazole Sodium Generic | 17 | 21 | Under 11 | $461 |
| Esomeprazole Magnesium Generic | 17 | 31 | Under 11 | $1,075 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 17 | 17 | 17 | $350 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 14 | 14 | 13 | $211 |
Brand drugs: 218 claims; generic drugs: 467 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joshua G Vandersteen $466 ($466 in general payments such as food, travel and fees) from 8 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $189.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 10 | $189 |
| Abbvie Inc. ABBV | 5 | $95.17 |
| Boston Scientific Corporation BSX | 1 | $47.69 |
| Janssen Biotech, Inc. JNJ | 2 | $38.49 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $34.13 |
| Pfizer Inc. PFE | 2 | $30.94 |
| Aimmune Therapeutics, Inc. | 1 | $15.91 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $14.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.